At the 2015 American Society of Hematology (ASH) conference, patient advocate Carol Preston and Dr. Christopher Yasenchak, from US Oncology Research, discuss encouraging news for Hodgkin lymphoma patients who are over 60 years old. Dr. Yasenchak explains why 50 percent of older patients cannot tolerate current potent chemo side effects and the exciting new combination treatments in pre-clinical trial that offer, as Dr. Yasenchak says a game-changing opportunity.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo